Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Watch for Abiomed Inc to Potentially Rebound After Falling 2.28% Yesterday

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $313.16 to a high of $322.14. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $322.87...

ABMD : 313.22 (-3.09%)
Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (revised)

The published data sets prove that Abbott's (ABT) MitraClip ensures the sustenance of long-term quality of life for patients of secondary or functional mitral regurgitation (MR).

ABT : 78.23 (+0.33%)
VAR : 138.71 (+0.09%)
ABMD : 313.22 (-3.09%)
MASI : 134.53 (+0.64%)
Here's Why You Should Retain Patterson Companies (PDCO) Stock

A diversified product portfolio and strong Dental business prospects provide Patterson Companies (PDCO) a competitive edge in the MedTech space.

WMGI : 31.68 (+0.19%)
PDCO : 21.63 (-2.92%)
ABMD : 313.22 (-3.09%)
IDXX : 219.24 (-0.09%)
Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (Revised)

The published data sets prove that Abbott's (ABT) MitraClip ensures the sustenance of long-term quality of life for patients of secondary or functional MR.

ABT : 78.23 (+0.33%)
VAR : 138.71 (+0.09%)
ABMD : 313.22 (-3.09%)
MASI : 134.53 (+0.64%)
Abiomed (ABMD) Gains As Market Dips: What You Should Know

Abiomed (ABMD) closed the most recent trading day at $339.28, moving +1.81% from the previous trading session.

ABMD : 313.22 (-3.09%)
Abiomed Inc Set to Possibly Pullback After Yesterday's Rally of 1.60%

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $330.99 to a high of $338.59. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

ABMD : 313.22 (-3.09%)
Boston Scientific (BSX) Rides on Acquisitions, Innovation

Boston Scientific (BSX) takes a big leap forward by closing the buyout of Millipede and inking a deal to purchase BTG plc.

VAR : 138.71 (+0.09%)
ABMD : 313.22 (-3.09%)
BSX : 37.64 (+0.91%)
MASI : 134.53 (+0.64%)
Boston Scientific's EP Arm Gets a Lift From Study Success

The positive result regarding Boston Scientific's (BSX) LUMINIZE RF Balloon Catheter is expected to help the company further advance with the procedures to clinch a CE Mark for the instrument.

VAR : 138.71 (+0.09%)
ABMD : 313.22 (-3.09%)
BSX : 37.64 (+0.91%)
MASI : 134.53 (+0.64%)
Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results

The published data sets prove that Abbott's (ABT) MitraClip ensures the sustenance of long-term quality of life for patients of secondary or functional mitral regurgitation (MR).

ABT : 78.23 (+0.33%)
ABMD : 313.22 (-3.09%)
VAR : 138.71 (+0.09%)
MASI : 134.53 (+0.64%)
Here's Why You Should Invest in Integer Holdings (ITGR) Stock

Integer Holdings (ITGR) is likely to gain from the Cardio & Vascular, Neuromodulation and Non-Medical Electrochem markets.

WMGI : 31.68 (+0.19%)
ITGR : 82.41 (-2.04%)
ABMD : 313.22 (-3.09%)
IDXX : 219.24 (-0.09%)
HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q4

HealthEquity (HQY) witnesses strong HSA member growth in the fourth quarter of fiscal 2019.

WMGI : 31.68 (+0.19%)
HQY : 73.57 (-0.28%)
ABMD : 313.22 (-3.09%)
IDXX : 219.24 (-0.09%)
Allscripts Partners With Opargo to Boost Practice Management

Allscripts' (MDRX) partnership with Opargo is likely to improve scheduling capabilities and practice workflows of Allscripts Practice Management solution.

WMGI : 31.68 (+0.19%)
ABMD : 313.22 (-3.09%)
MDRX : 9.91 (+0.10%)
IDXX : 219.24 (-0.09%)
Omnicell's Global Expansion on Track, Stiff Competition Ails

Although Omnicell (OMCL) is steadily expanding in the Middle East and South African belts, it sees a greater uptake of technologies across other regions of the world.

OMCL : 79.75 (-0.28%)
VAR : 138.71 (+0.09%)
ABMD : 313.22 (-3.09%)
MASI : 134.53 (+0.64%)
Is ABIOMED (ABMD) Outperforming Other Medical Stocks This Year?

Is (ABMD) Outperforming Other Medical Stocks This Year?

ABMD : 313.22 (-3.09%)
BioScrip (BIOS) Reports Loss in Q4, Both Margins Contract

The combined expertise of BioScrip (BIOS) and OptionCare is expected to drive significant growth for the former.

BIOS : 2.10 (+10.53%)
ABMD : 313.22 (-3.09%)
VAR : 138.71 (+0.09%)
CNMD : 80.75 (+1.17%)
Impella RP Post-Approval Study Data Presented at ACC 2019

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies and the maker of the Impella RP heart pump, announces that survival data from the 18 month ...

ABMD : 313.22 (-3.09%)
Stryker Buys Israel-Based OrthoSpace, Strengthens MedSurg

Strong international presence and an acquisition-driven strategy are likely to fortify Stryker's (SYK) footprint in the global MedTech space.

WMGI : 31.68 (+0.19%)
SYK : 195.17 (+0.38%)
ABMD : 313.22 (-3.09%)
IDXX : 219.24 (-0.09%)
Integra's Duragen Secures Japanese Nod to Drive Global Growth

Despite facing adverse foreign exchange volatility across its international business, Integra LifeSciences (IART) can successfully eye certain key developments on foreign shores.

ABMD : 313.22 (-3.09%)
PEN : 157.25 (-0.45%)
IART : 55.11 (-0.33%)
MASI : 134.53 (+0.64%)
Abbott (ABT) Gets FDA Approval for Expanded Use of MitraClip

The FDA approval is expected to strengthen Abbott's (ABT) structural heart business.

ABT : 78.23 (+0.33%)
ABMD : 313.22 (-3.09%)
VAR : 138.71 (+0.09%)
MASI : 134.53 (+0.64%)
Allscripts Strengthens Strategic Relationship with Pulse8

Pulse8 is likely to boost Allscripts' (MDRX) flagship platform Veradigm, and its existing health plan product suite that delivers pocket-friendly tools and services for health plan members.

WMGI : 31.68 (+0.19%)
ABMD : 313.22 (-3.09%)
MDRX : 9.91 (+0.10%)
IDXX : 219.24 (-0.09%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.11
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar